Tumor Necrosis Factor Ligand Superfamily Member 11 / RANKL (TNFSF11) Antibody... Reference: abx117369
Daxdilimab Reference: HY-P99226 Daxdilimab is an anti-ILT7 monoclonal antibody, ILT7 is a cell surface molecule specific to the pDC type of dendritic cells. Daxdilimab can be used in acute lung injury (ALI) in patients with COVID-19 infection research.
Patritumab Reference: HY-P99275 Patritumab (Human Anti-ERBB3 Recombinant Antibody) is a neutralizing monoclonal antibody to ERBB3. Patritumab shows a synergy with Cetuximab (HY-P9905), potently inhibits the phosphorylation of EGFR, HER2, HER3, ERK, and AKT. Patritumab also induces cell apoptosis and suppresses the growth of pancreatic, non-small cell lung cancer, and colorectal cancer xenograft tumors.
Sibrotuzumab Reference: HY-P99269 Sibrotuzumab (BIBH 1) is a humanized IgG1 monoclonal antibody targets fibroblast activation protein (FAP). Sibrotuzumab can be used for the research of colorectal cancer and non-small cell lung cancer (NSCLC).
Galegenimab Reference: HY-P99629 Galegenimab (FHTR 2163; RG 6147; RO 7171009), an anti-High-temperature requirement A1 (HTRA1) antibody fragment. Galegenimab can be used for age-related macular degeneration (AMD) research.
Enapotamab Reference: HY-P99360 Enapotamab is an anti-AXL/UFO reference antibody. Enapotamab can be used to synthesis Bcl-xl inhibitor antibody-drug conjugates.
Anti-Mouse CD90 Antibody Reference: HY-P99130 Anti-Mouse CD90 Antibody is a anti-mouse CD90 IgG2b antibody inhibitor derived from host Rat.